Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: The Chicago Heart Association Detection Project in Industry study

Diabetes Care

Volumn 20, Issue 2, 1997, Pages 163-169

  Lowe, Lynn P ^a   Liu, Kiang ^a   Greenland, Philip ^a   Metzger, Boyd E ^a   Dyer, Alan R ^a   Stamler, Jeremiah ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERGLYCEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MORTALITY; NEGRO; RACE DIFFERENCE; RISK ASSESSMENT;

EID: 0031018988     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.2.163     Document Type: Article

References (50)

1. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes 36:523-534, 1987
2. National Center for Health Statistics: Advance report of final mortality statistics, 1992. In Monthly Vital Statistics Report (Suppl.) 43. Hyattsville, MD, Public Health Service, 1994, p. 8
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
4. Reunanen A: Mortality in type 2 diabetes. Ann Clin Res 15 (Suppl.):26-28, 1983
5. Barrett-Connor E, Wingard DL: Sex differential in ischemic heart disease mortality in diabetics: a prospective population based study. Am J Epidemiol 118:489-496, 1983
6. Butler WJ, Ostrander LD Jr, Carman WJ, Lamphiear DE: Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 121:541-547, 1985
7. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986
8. Cruz-Vidal M, Garcia-Palmieri MR, Costas R Jr, Sorlie PD, Havlik RJ: Abnormal blood glucose and coronary heart disease: the Puerto Rico Heart Health Program. Diabetes Care 6:556-561, 1983
9. Jarrett RJ, Shipley MJ: Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease-putative association via common antecedents: further evidence from the Whitehall Study. Diabetologia 31:737-740, 1988
10. Kleinman JC, Donahue RF, Harris MI, Finucane FF, Madans JH, Brock DB: Mortality among diabetics in a national sample. Am J Epidemiol 128:389-401, 1988
11. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. Br Med J 299:1127-1131, 1989
12. Balkau B, Eschwege E, Ducimetiere P, Richard J-L, Warnet J-M: The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris Prospective Study after 15 years of follow-up. J Clin Epidemiol 44:465-474, 1991
13. Centers for Disease Control: Trends in diabetes mortality. MMWR 37:769-773, 1988
14. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study Br Med J 287:867-870, 1983
15. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652, 1993
16. Karasik A, Modan M, Halkin H, Treister G, Fuchs Z, Lusky A: Senile cataract and glucose intolerance: the Israel Study of Glucose Intolerance, Obesity and Hypertension (The Israel GOH Study). Diabetes Care 7:52-56, 1984
17. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
18. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646), p. 9-14
19. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE: Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res 15 (Suppl.):41-46, 1985
20. Feskens EJM, Kromhout D: Glucose tolerance and the risk of cardiovascular diseases: the Zutphen Study. J Clin Epidemiol 45:1327-1334, 1992
21. Scheidt-Nave C, Barrett-Connor E, Wingard DL, Cohn BA, Edelstein SL: Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol 133:565-576, 1991
22. Vaccaro O, Ruth KJ, Stamler J: Relationship of postload plasma glucose to mortality with 19-yr follow-up: comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company Study. Diabetes Care 15:1328-1334, 1992
23. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-160, 1979
24. Stamler R, Stamler J, Schoenberger JA, Shekelle RB, Collette P, Shekelle S, Dyer A, Garside D, Wannamaker J: Relationship of glucose tolerance to prevalence of ECG abnormalities and to 5-year mortality from cardiovascular disease: findings of the Chicago Heart Association Detection Project in Industry. J Chron Dis 32:817-828, 1979
25. Stamler R, Stamler J, Lindberg HA, Marquardt J, Berkson DM, Paul O, Lepper M, Dyer A, Stevens E: Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago. J Chron Dis 32:805-815, 1979
26. Stamler R, Stamler J (Eds.): Asymptomatic hyperglycemia and coronary heart disease. A series of papers by the International Collaborative Group based on studies in fifteen populations. J Chronic Dis 32:683-837, 1979
27. Balkau B, Eschwege E, Papoz L, Richard J-L, Claude J-R, Warnet J-M, Ducimetiere P: Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. Br Med J 307:295-299, 1993
28. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program. Diabetes 36:689-692, 1987
29. Cooper R, Liu K, Stamler J, Schoenberger JA, Shekelle RB, Collette P, Shekelle S: Prevalence of diabetes/hyperglycemia and associated cardiovascular risk factors in blacks and whites: Chicago Heart Association Detection Project in Industry. Am Heart J 108:827-833, 1984
30. Stamler J, Stamler R, Rhomberg P, Dyer A, Berkson DM, Reedus W, Wannamaker J: Multivariate analysis of the relationship of six variables to blood pressure: findings from Chicago community surveys, 1965-1971. J Chronic Dis 28:499-525, 1975
31. Stamler J, Rhomberg P, Schoenberger JA, Shekelle RB, Dyer A, Shekelle S, Stamler R, Wannamaker J: Multivariate analysis of the relationship of seven variables to blood pressure: findings of the Chicago Heart Association Detection Project in Industry, 1967-1972. J Chronic Dis 28:527-548, 1975
32. Hoffman WS: A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem 120:51-55, 1937
33. Cedres LB, Liu K, Stamler J, Dyer AR, Stamler R, Berkson DM, Paul O, Lepper M, Lindberg HA, Marquardt J, Stevens E, Schoenberger JA, Shekelle RB, Collette P, Garside D: Independent contribution of electrocardiographic abnormalities to risk of death from coronary heart disease, cardiovascular disease and all causes: findings of three Chicago epidemiologic studies. Circulation 65:146-153, 1982
34. The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis 31:201-306, 1978
35. National Center for Health Statistics: International Classification of Diseases (Adapted for use in the US), 8th revision. Washington, DC, U.S. Govt. Printing Office, 1967
36. National Cholesterol Education Program: Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Bethesda, MD, National Institutes of Health, National Heart, Lung, and Blood Institute; National Cholesterol Education Program, 1990. US Department of Health and Human Services publication NIH 90-3046
37. U.S. Public Health Service, National Institutes of Health: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Washington, DC, U.S. Department of Health and Human Services, 1993 (93-1088)
38. National Center for Health Statistics: Health, United States, 1987. Washington, DC, U.S. Govt. Printing Office, 1988 (PHS 88-1232)
39. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA: Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med 329:73-78, 1993
40. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study Diabetes Care 2:120-126, 1979
41. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L: Is borderline hyperglycemia a risk factor for cardiovascular death? J Chron Dis 37:773-779, 1984
42. Pyorala K, Savolainen E, Kaukola S, Haapakoski J: Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 701 (Suppl.):38-52, 1985
43. Wilson PWF, Cupples LA, Kannel WB: Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 121:586-590, 1991
44. Donahue RP, Orchard TJ: Diabetes mellitus and macrovascular complications. Diabetes Care 15:1141-1155, 1992
45. Liu K, Stamler J, Stamler R, Cooper R, Shekelle RB, Schoenberger JA, Berkson DM, Lindberg HA, Marquardt J, Stevens E, Tokich T: Methodological problems in characterizing an individual's plasma glucose level. J Chron Dis 35:475-485, 1982
46. Liu K: Measurement error and its impact on partial correlation and multiple linear regression analyses. Am J Epidemiol 127:864-874, 1988
47. Harris MI: Epidemiological correlates of NIDDM in Hispanics, whites, and blacks in the U.S. population. Diabetes Care 14 (Suppl. 3):639-648, 1991
48. Yano K, Kagan A, McGee D, Rhoads GG: Glucose intolerance and nine-year mortality in Japanese men in Hawaii. Am J Med 72:71-80, 1982
49. Zavaroni I, Dall'Aglio E, Bonora E, Alpi O, Passen M, Reaven GM: Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med 83:609-612, 1987
50. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R: Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology 82:191-222, 1993